SIA
MCRB icon

Sit Investment Associates’s Seres Therapeutics MCRB Stock Holding History

Sit Investment Associates’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,110
Closed -$265K – 540
2024
Q1 		$265K Hold
17,110
– – 0.01% 442
2023
Q4 		$479K Hold
17,110
– – 0.01% 413
2023
Q3 		$814K Buy
17,110
+3,994
+30% +$305K 0.02% 358
2023
Q2 		$1.26M Hold
13,116
– – 0.03% 342
2023
Q1 		$1.49M Sell
13,116
-134
-1% -$14.5K 0.04% 323
2022
Q4 		$1.48M Buy
13,250
+3,300
+33% +$442K 0.04% 323
2022
Q3 		$1.28M Hold
9,950
– – 0.04% 320
2022
Q2 		$683K Buy
9,950
+6,827
+219% +$588K 0.02% 359
2022
Q1 		$445K Hold
3,123
– – 0.01% 417
2021
Q4 		$520K Hold
3,123
– – 0.01% 411
2021
Q3 		$435K Hold
3,123
– – 0.01% 410
2021
Q2 		$1.49M Buy
+3,123
New +$1.32M 0.04% 330

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sit Investment Associates's MCRB Position: Q2 2024 in Review

Sit Investment Associates sold out of Seres Therapeutics (MCRB) in Q2 2024, closing a stake of 17,110 shares — an estimated $265K sold.

Sit Investment Associates first reported a position in MCRB in Q2 2021 and held it in 12 quarters. The position peaked at $1.49M in Q2 2021. 93 funds tracked by Wall St. Rank hold MCRB as of Q2 2024.

  • Sit Investment Associates reported no remaining Seres Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Sit Investment Associates sold 17,110 Seres Therapeutics shares in Q2 2024, an estimated $265K.
  • Sit Investment Associates first reported a position in Seres Therapeutics in Q2 2021 and held it in 12 quarters.
  • Sit Investment Associates's Seres Therapeutics position peaked at $1.49M in Q2 2021.
  • 93 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2024.

Based on Sit Investment Associates's 13F filing for Q2 2024, filed 14 Aug 2024.